Evidence for kinase inhibitor activity in acute myeloid leukaemia
0 Views
administrator
07/04/23
Visit http://www.ecancer.org for more
Dr Ehninger (University Hospital Dresden, Dresden, Germany) talks to ecancertv at EHA 2015 about the results of a phase II randomised study on the safety and efficacy of sorafenib in leukaemia.
-
Category
Show more
Facebook Comments
No comments found